Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery

NANot yet recruitingINTERVENTIONAL
Enrollment

90

Participants

Timeline

Start Date

May 15, 2025

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Tooth ExtrusionWound Healing
Interventions
DEVICE

OROXID® forte oral solution

Patients will use OROXID® forte oral solution two to three times daily for 14 days as an adjunct to standard care.

DEVICE

OROXID® sensitive oral solution

Patients will use OROXID® sensitive oral solution two to three times daily for 14 days as an adjunct to standard care.

OTHER

Standard of Care (SOC)

Patients will receive standard of care meaning proper tooth brushing without the use of any mouthwash or other products aimed at reducing bacteria in the oral cavity.

Trial Locations (1)

1295

Klinika Križaj, Muljava

All Listed Sponsors
lead

ENIKAM d.o.o.

INDUSTRY

NCT06987253 - Assessment of the Efficacy and Safety of OROXID® Oral Solution in Patients With Oral Cavity Surgery | Biotech Hunter | Biotech Hunter